STATE STREET CORP - FIVE PRIME THERAPEUTICS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$70,046,000
+319.4%
1,859,461
+89.4%
0.00%
+300.0%
Q4 2020$16,703,000
+395.8%
981,924
+37.0%
0.00%
Q3 2020$3,369,000
-17.8%
716,824
+6.7%
0.00%
Q2 2020$4,098,000
+193.6%
671,840
+9.2%
0.00%
Q1 2020$1,396,000
-51.5%
615,025
-1.8%
0.00%
Q4 2019$2,876,000
+11.9%
626,555
-5.5%
0.00%
Q3 2019$2,571,000
-36.3%
663,359
-0.8%
0.00%
Q2 2019$4,034,000
-77.0%
669,035
-49.0%
0.00%
-100.0%
Q1 2019$17,569,000
+48.4%
1,311,113
+3.0%
0.00%0.0%
Q4 2018$11,840,000
-44.1%
1,273,135
-16.3%
0.00%
-50.0%
Q3 2018$21,183,000
-29.7%
1,521,721
-20.2%
0.00%
-33.3%
Q2 2018$30,132,000
-13.4%
1,906,183
-5.8%
0.00%0.0%
Q1 2018$34,781,000
-9.0%
2,024,585
+16.2%
0.00%0.0%
Q4 2017$38,210,000
-7.4%
1,742,994
+72.8%
0.00%
-25.0%
Q3 2017$41,268,000
+1.2%
1,008,777
-25.5%
0.00%0.0%
Q2 2017$40,782,000
-9.7%
1,354,597
+8.4%
0.00%0.0%
Q1 2017$45,175,000
-9.3%
1,249,520
+25.7%
0.00%
-20.0%
Q4 2016$49,809,000
-10.6%
994,032
-6.3%
0.01%
-16.7%
Q3 2016$55,691,000
+27.3%
1,061,061
+0.3%
0.01%
+20.0%
Q2 2016$43,741,000
+30.8%
1,057,836
+28.5%
0.01%
+25.0%
Q1 2016$33,443,000
+24.1%
823,188
+26.8%
0.00%
+33.3%
Q4 2015$26,950,000
+15.9%
649,350
-57.0%
0.00%0.0%
Q3 2015$23,260,000
-35.0%
1,511,246
+4.9%
0.00%
-25.0%
Q2 2015$35,783,000
+40.5%
1,440,588
+29.3%
0.00%
+33.3%
Q1 2015$25,468,000
+352.9%
1,114,514
+435.5%
0.00%
+200.0%
Q4 2014$5,623,000
+153.7%
208,131
+10.1%
0.00%
Q3 2014$2,216,000
-17.3%
189,016
+9.7%
0.00%
Q2 2014$2,680,000
+64.8%
172,366
+108.6%
0.00%
Q1 2014$1,626,000
+131.0%
82,649
+97.2%
0.00%
Q4 2013$704,00041,9120.00%
Other shareholders

There were no reported owners of FIVE PRIME THERAPEUTICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of FIVE PRIME THERAPEUTICS INC shareholders